FR2046920B1 - - Google Patents

Info

Publication number
FR2046920B1
FR2046920B1 FR7022736A FR7022736A FR2046920B1 FR 2046920 B1 FR2046920 B1 FR 2046920B1 FR 7022736 A FR7022736 A FR 7022736A FR 7022736 A FR7022736 A FR 7022736A FR 2046920 B1 FR2046920 B1 FR 2046920B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7022736A
Other versions
FR2046920A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Citizen Watch Co Ltd
Original Assignee
Citizen Watch Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4844369A external-priority patent/JPS4826791B1/ja
Priority claimed from JP5816769U external-priority patent/JPS4829485Y1/ja
Application filed by Citizen Watch Co Ltd filed Critical Citizen Watch Co Ltd
Publication of FR2046920A1 publication Critical patent/FR2046920A1/fr
Application granted granted Critical
Publication of FR2046920B1 publication Critical patent/FR2046920B1/fr
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G04—HOROLOGY
    • G04B—MECHANICALLY-DRIVEN CLOCKS OR WATCHES; MECHANICAL PARTS OF CLOCKS OR WATCHES IN GENERAL; TIME PIECES USING THE POSITION OF THE SUN, MOON OR STARS
    • G04B19/00—Indicating the time by visual means
    • G04B19/24—Clocks or watches with date or week-day indicators, i.e. calendar clocks or watches; Clockwork calendars
    • G04B19/243—Clocks or watches with date or week-day indicators, i.e. calendar clocks or watches; Clockwork calendars characterised by the shape of the date indicator
    • G04B19/247—Clocks or watches with date or week-day indicators, i.e. calendar clocks or watches; Clockwork calendars characterised by the shape of the date indicator disc-shaped
    • G04B19/25—Devices for setting the date indicators manually
    • G—PHYSICS
    • G04—HOROLOGY
    • G04B—MECHANICALLY-DRIVEN CLOCKS OR WATCHES; MECHANICAL PARTS OF CLOCKS OR WATCHES IN GENERAL; TIME PIECES USING THE POSITION OF THE SUN, MOON OR STARS
    • G04B11/00—Click devices; Stop clicks; Clutches
    • G04B11/006—Clutch mechanism between two rotating members with transfer of movement in only one direction (free running devices)
FR7022736A 1969-06-19 1970-06-19 Expired FR2046920B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4844369A JPS4826791B1 (fr) 1969-06-19 1969-06-19
JP5816769U JPS4829485Y1 (fr) 1969-06-19 1969-06-19

Publications (2)

Publication Number Publication Date
FR2046920A1 FR2046920A1 (fr) 1971-03-12
FR2046920B1 true FR2046920B1 (fr) 1974-05-03

Family

ID=26388715

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7022736A Expired FR2046920B1 (fr) 1969-06-19 1970-06-19

Country Status (4)

Country Link
US (1) US3645090A (fr)
DE (1) DE2031216A1 (fr)
FR (1) FR2046920B1 (fr)
GB (1) GB1319315A (fr)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5149971Y2 (fr) * 1971-02-17 1976-12-02
CH543763A (fr) * 1971-05-05 1973-04-13 Ebauches Sa Pièce d'horlogerie à calendrier
CH584926B5 (fr) * 1971-10-06 1977-02-15 Suisse Horlogerie
CH577197B5 (fr) * 1971-10-29 1976-06-30 Ebauches Sa
US3969888A (en) * 1972-12-11 1976-07-20 Cyril Veuilleumier Driving mechanism for day-date calendar device
DE2824917A1 (de) 1977-07-13 1979-02-01 Corning Glass Works Biologisch aktive konjugate
JPH0235944B2 (ja) * 1980-06-20 1990-08-14 Unilever Nv Tokuitekiketsugokenteiojitsushisuruhohooyobigaihohoojitsushisurutamenoshikenkitsuto
US4443112A (en) * 1982-09-29 1984-04-17 Timex Corporation Planetary gear for date mechanism in a wristwatch
JPS62231168A (ja) 1986-03-21 1987-10-09 ハイブリテツク・インコ−ポレイテツド アナライト−レセプタ−分析用内部標準を設けるための改良法
US6562333B1 (en) 1993-06-14 2003-05-13 Schering Corporation Purified mammalian CTLA-8 antigens and related reagents
US5869451A (en) 1995-06-07 1999-02-09 Glaxo Group Limited Peptides and compounds that bind to a receptor
EP1961760A3 (fr) 1995-06-07 2008-09-03 Glaxo Group Limited Peptides et composés se liant à un récepteur de la thrombopoïétine
EP1947183B1 (fr) 1996-08-16 2013-07-17 Merck Sharp & Dohme Corp. Antigène de surface de cellule de mammifère; agents chimiques relatifs
EP1995318A1 (fr) 1996-12-13 2008-11-26 Schering Corporation Antigènes de surface de cellule de mammifère ; agents chimiques relatifs
ES2279572T3 (es) 1997-05-07 2007-08-16 Schering Corporation Proteinas receptoras humanas de tipo toll, reactivos y metodos relacionados.
AU755279C (en) 1997-07-09 2004-02-19 Schering Corporation Isolated dendritic cell membrane protein genes
PE20000183A1 (es) 1997-07-25 2000-03-11 Schering Corp Citoquinas de mamiferos y reactivos relacionados
ATE341626T1 (de) 1997-08-01 2006-10-15 Schering Corp Membranproteine aus säugetierzellen; verwandte reagentien
CA2333931C (fr) 1998-07-15 2013-09-03 Brigham And Women's Hospital, Inc. Vaccin de polysaccharide contre les infections a staphyloccoques
EP1115867A1 (fr) 1998-09-21 2001-07-18 Schering Corporation Interleukine humaine b50, ses utilisations therapeutiques
EP0997476A3 (fr) 1998-09-25 2000-07-19 Schering-Plough Anticorps contre un antigène de cellules Langerhans mammifères et leurs utilisations
EP1141297B1 (fr) 1999-01-11 2009-09-30 Schering Corporation Cytokines de mammiferes liees a l'interleukin-17, polynucleotides les codant et leurs utilisations
NZ515382A (en) 1999-05-13 2004-03-26 Medical Res Council OX2 receptor homologs
ATE424456T1 (de) 1999-06-01 2009-03-15 Schering Corp Säugetier-rezeptorproteine; ähnliche reagentien und methoden
EP1192258A2 (fr) 1999-06-16 2002-04-03 Icos Corporation Materiaux poly(adp-ribose) polymerase 2 humains et procedes
WO2001009176A2 (fr) 1999-07-30 2001-02-08 Schering Corporation Cytokines mammaliennes; reactifs correspondants
US7668658B2 (en) * 1999-10-13 2010-02-23 Sequenom, Inc. Methods for generating databases and databases for identifying polymorphic genetic markers
US7109299B1 (en) 1999-12-16 2006-09-19 Affymax, Inc. Peptides and compounds that bind to the IL-5 receptor
US7422743B2 (en) 2000-05-10 2008-09-09 Schering Corporation Mammalian receptor protein DCRS5;methods of treatment
KR100869621B1 (ko) 2000-05-10 2008-11-21 쉐링 코포레이션 포유류 수용체 단백질, 관련 시약 및 방법
IL152725A0 (en) 2000-05-25 2003-06-24 Schering Corp Human receptor proteins, related reagents and methods
US7060800B2 (en) 2000-09-08 2006-06-13 Schering Corporation Antibodies binding the TNF related protein, TNF-X
US6890734B2 (en) 2000-11-10 2005-05-10 Schering Corporation Nucleic acids encoding a cytokine receptor complex
US7087726B2 (en) 2001-02-22 2006-08-08 Genentech, Inc. Anti-interferon-α antibodies
WO2002072786A2 (fr) 2001-03-13 2002-09-19 Corvas International, Inc. Molecules d'acides nucleiques codant pour une serine protease transmembranaire 7, polypeptides codes et procedes associes
AU2002254357A1 (en) 2001-03-22 2002-10-08 Dendreon Corporation Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon
CA2442089A1 (fr) 2001-03-27 2002-10-03 Dendreon San Diego Llc Molecules d'acide nucleique codant une serine protease transmembranaire 9, polypeptides codes et procedes fondes sur ces derniers
US7112430B2 (en) 2001-05-14 2006-09-26 Dendreon Corporation Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
EP1439188A4 (fr) 2001-09-25 2006-04-26 Japan Government Nouveau procede de criblage dans la recherche d'un marqueur du cancer
EP1439857B1 (fr) 2001-10-12 2009-02-25 Schering Corporation UTILISATION D'ANTICORPS BISPECIFIQUES RECONNAISSANT LE RECEPTEUR D'ACTIVATION FcEpsilon RI ET LE RECEPTEUR D'INHIBITION OX2Ra (CD200Ra) POUR REGULER DES REPONSES IMMUNITAIRES
AU2002357004A1 (en) * 2001-11-20 2003-06-10 Dendreon San Diego Llc Nucleic acid molecules encoding serine protease 17, the encoded polypeptides and methods based thereon
AU2003228809A1 (en) * 2002-05-03 2003-11-17 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof, and related methods
US20040001801A1 (en) * 2002-05-23 2004-01-01 Corvas International, Inc. Conjugates activated by cell surface proteases and therapeutic uses thereof
US7575893B2 (en) * 2003-01-23 2009-08-18 Genentech, Inc. Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
WO2005067692A2 (fr) * 2004-01-13 2005-07-28 U.S. Genomics, Inc. Detection et quantification d'analytes en solution a l'aide de polymeres
ZA200608572B (en) * 2004-04-16 2008-06-25 Genentech Inc Assay for antibodies
ES2395087T3 (es) 2004-05-05 2013-02-08 Valorisation-Recherche, Société en Commandite Antagonistas del receptor de interleuquina-1, composiciones y métodos de tratamiento
US20060014680A1 (en) * 2004-07-13 2006-01-19 Caiding Xu Peptides and compounds that bind to the IL-5 receptor
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
MX2007001589A (es) * 2004-08-09 2007-08-02 Alios Biopharma Inc Variantes de polipeptido resistentes a proteasa, hiperglicosiladas sinteticas, formulaciones orales y metodos para utilizar las mismas.
EP1885855A4 (fr) 2005-05-05 2009-03-04 Valorisation Hsj Soc En Comman Modulateurs du récepteur de la cytokine et leurs utilisations
US20100015654A1 (en) * 2005-05-16 2010-01-21 Institut De Recherches Cliniques De Montreal/ I.R.C.M. Negative regulation of NK cell functions by EAT-2, a sap-related adaptor expressed in innate immune cells
WO2007056250A2 (fr) * 2005-11-04 2007-05-18 U.S. Genomics, Inc. Analyse heterogene d'analytes en solution au moyen de polymeres
AU2007248444B2 (en) 2006-01-05 2012-10-25 Genentech, Inc. Anti-EphB4 antibodies and methods using same
AU2007210068A1 (en) 2006-01-26 2007-08-09 The Board Of Regents, The University Of Texas System Process and apparatus for imaging
AR059851A1 (es) 2006-03-16 2008-04-30 Genentech Inc Anticuerpos de la egfl7 y metodos de uso
EP2069778A2 (fr) * 2006-08-03 2009-06-17 Numira Biosciences, Inc. Procedes et compositions pour l'identification de bio-marqueurs
TWI541251B (zh) 2006-10-04 2016-07-11 建南德克公司 用於ｖｅｇｆ之ｅｌｉｓａ
US20080171344A1 (en) * 2006-12-22 2008-07-17 Kapsner Kenneth P Methods, Kits and Materials for Diagnosing Disease States by Measuring Isoforms or Proforms of Myeloperoxidase
PE20090321A1 (es) 2007-06-04 2009-04-20 Genentech Inc Anticuerpos anti-notch1 nrr, metodo de preparacion y composicion farmaceutica
EP2197911A2 (fr) 2007-09-14 2010-06-23 Amgen Inc. Populations d'anticorps homogènes
AR069501A1 (es) 2007-11-30 2010-01-27 Genentech Inc Anticuerpos anti- vegf (factor de crecimiento endotelial vascular)
AU2009279682B2 (en) 2008-08-04 2015-01-22 University Of Miami STING (stimulator of interferon genes), a regulator of innate immune responses
CA2778810C (fr) * 2009-10-26 2018-09-04 Genentech, Inc. Essais pour detecter des anticorps specifiques d'anticorps anti-ige therapeutiques et leur utilisation en anaphylaxie
US8361744B2 (en) 2009-11-05 2013-01-29 Genentech, Inc. Methods and composition for secretion of heterologous polypeptides
TWI505836B (zh) 2009-12-11 2015-11-01 Genentech Inc 抗－ｖｅｇｆ－ｃ抗體及其使用方法
PL2516465T3 (pl) 2009-12-23 2016-11-30 Przeciwciała anty-bv8 i ich zastosowania
WO2011091435A2 (fr) 2010-01-25 2011-07-28 Mount Sinai School Of Medicine Méthodes de traitement de maladies hépatiques
WO2012030738A2 (fr) 2010-08-30 2012-03-08 Beckman Coulter, Inc. Profils complexes d'activation de phosphoprotéines
WO2012092539A2 (fr) 2010-12-31 2012-07-05 Takeda Pharmaceutical Company Limited Anticorps contre dll4 et leurs utilisations
EP2702076A1 (fr) 2011-04-29 2014-03-05 Bristol-Myers Squibb Company Schémas posologiques à doses progressivement croissantes d'anticorps anti-ip-10
ES2641325T3 (es) 2012-01-26 2017-11-08 Christopher J. Soares Antagonistas peptídicos de la familia calcitonina CGRP de hormonas peptídicas y su uso
EP2822571A4 (fr) 2012-02-16 2016-03-09 Penn State Res Found Modulateurs de l'acyl-coa lysocardiolipine acyltransférase 1 (alcat1) et leurs utilisations
US20150079100A1 (en) 2012-03-23 2015-03-19 Bristol-Myers Squibb Company Methods of treatments using ctla-4 antibodies
EP2831119A1 (fr) 2012-03-28 2015-02-04 F. Hoffmann-La Roche AG Anticorps idiotypiques anti-hcmv et leurs utilisations
BR112014030025A2 (pt) 2012-05-30 2017-06-27 Brigham & Womens Hospital Inc composições de polissacarídeo e métodos de uso
SG11201500938XA (en) 2012-08-31 2015-04-29 Immunogen Inc Diagnostic assays and kits for detection of folate receptor 1
US9733263B2 (en) 2012-11-07 2017-08-15 Lotus Tissue Repair Inc. Collagen IV binding assay for the detection of collagen VII
MX371496B (es) 2013-08-30 2020-01-31 Immunogen Inc Anticuerpos y ensayos para la detección del receptor 1 de folato.
KR102571391B1 (ko) 2013-09-13 2023-08-29 제넨테크, 인크. 정제된 재조합 폴리펩티드를 포함하는 방법 및 조성물
PL3044323T3 (pl) 2013-09-13 2022-06-27 F.Hoffmann-La Roche Ag Sposoby wykrywania i ilościowego oznaczania białka komórki gospodarza w liniach komórkowych
US10073082B2 (en) 2013-10-18 2018-09-11 Beckman Coulter, Inc. Proteasome inhibition assay and methods of use
HRP20211748T1 (hr) 2014-03-14 2022-02-18 F. Hoffmann - La Roche Ag Postupci i sastavi za sekreciju heterolognih polipeptida
EP3212773B1 (fr) 2014-10-29 2021-09-15 Massachusetts Eye and Ear Infirmary Administration efficace de molécules thérapeutiques en direction de cellules de l'oreille interne
WO2016069912A1 (fr) 2014-10-29 2016-05-06 Massachusetts Eye And Ear Infirmary Admnistration efficace de molécules thérapeutiques in vitro et in vivo
US10073098B2 (en) 2015-03-06 2018-09-11 Genentech, Inc. Ultrapurified DsbA and DsbC and methods of making and using the same
JP6492928B2 (ja) * 2015-04-22 2019-04-03 セイコーエプソン株式会社 時計および時計の製造方法
JP6914919B2 (ja) 2015-08-28 2021-08-04 ジェネンテック， インコーポレイテッド 抗ヒプシン抗体及びその使用
WO2017106527A1 (fr) 2015-12-15 2017-06-22 Case Western Reserve University Évaluation de cancer épithélial à l'aide la bêta-défensine
MX2018012550A (es) 2016-04-14 2019-07-08 Lonza Ag Composiciones y metodos para la deteccion de proteinas de celulas huesped.
EP3316048B1 (fr) * 2016-10-28 2020-03-18 Rolex Sa Mécanisme horloger d'affichage et de correction d'une pluralité d'informations
AU2018211064A1 (en) 2017-01-18 2019-09-05 Genentech, Inc. Idiotypic antibodies against anti-PD-L1 antibodies and uses thereof
CH713604A1 (fr) 2017-03-22 2018-09-28 Sa De La Manufacture Dhorlogerie Audemars Piguet & Cie Mécanisme de sélection et d'actionnement ainsi que dispositif de réglage de fonctions d'une pièce d'horlogerie.
JP6740323B2 (ja) * 2017-07-25 2020-08-12 ブランパン・エス アー 計時器、特に、ストライク機構を備えた計時器、のためのトルクの平滑化
EP3584643B1 (fr) * 2018-06-19 2020-11-11 Manufacture d'Horlogerie Audemars Piguet SA Dispositif de commande instantanée pour un affichage de quantième d'une pièce d'horlogerie
EP3667435B1 (fr) 2018-12-10 2022-06-01 Montres Breguet S.A. Systeme de reglage de la position d'un premier mobile dente par rapport a un support sur lequel le premier mobile dente est monte pivotant et piece d'horlogerie comprenant un tel systeme
EP3786725A1 (fr) * 2019-08-26 2021-03-03 Blancpain SA Débrayage de deux trains d'engrenage
BR112022022021A2 (pt) 2020-04-30 2022-12-13 Genentech Inc Anticorpos, ácido(s) nucleico(s), vetor, célula hospedeira, processo para produzir um anticorpo, métodos para rastrear um anticorpo, detectar kras-gdp, obter um inibidor, detectar a alquilação de kras, tratar um câncer, rastrear compostos, medir a ligação de uma proteína e medir o engajamento do alvo de um inibidor, kit, chaperona de cristalização, método de cristalização e superfície de biossensor
EP4229081A1 (fr) 2020-10-15 2023-08-23 The United States of America, as represented by The Secretary, Department of Health and Human Services Anticorps spécifique du domaine de liaison du récepteur du sars-cov-2 et procédés thérapeutiques
WO2022087274A1 (fr) 2020-10-21 2022-04-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Anticorps qui neutralisent l'activité de l'interféron de type i (ifn)
AU2022224636A1 (en) 2021-02-19 2023-09-07 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Single domain antibodies that neutralize sars-cov-2

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH323982A (fr) * 1955-07-23 1957-08-31 Rolex Montres Pièce d'horlogerie à calendrier
CH394959A (fr) * 1963-03-08 1965-03-15 Tavannes Watch Co Sa Montre à remontage automatique, comprenant un dispositif manuel de mise à l'heure et de remontage et un quantième
DE1242512B (de) * 1964-08-25 1967-06-15 United States Time Corp Anzeigevorrichtung an einer Uhr zum Anzeigen einer Vielzahl von Kalenderinformationen
US3470687A (en) * 1966-12-15 1969-10-07 Suwa Seikosha Kk Date and day correcting device of a calendar timepiece
US3470688A (en) * 1967-07-26 1969-10-07 Suwa Seikosha Kk Date and day correcting device of a calendar timepiece

Also Published As

Publication number Publication date
DE2031216A1 (de) 1971-01-14
GB1319315A (en) 1973-06-06
US3645090A (en) 1972-02-29
FR2046920A1 (fr) 1971-03-12

Similar Documents

Publication Publication Date Title
FR2046920B1 (fr)
AU2270770A (fr)
AU465452B2 (fr)
AU4221168A (fr)
AU450150B2 (fr)
AU2355770A (fr)
AU442375B2 (fr)
AU427401B2 (fr)
AU470301B1 (fr)
AU442322B2 (fr)
AU414607B2 (fr)
AU442538B2 (fr)
AU438128B2 (fr)
AU470661B1 (fr)
AT308690B (fr)
AU442285B2 (fr)
AU428074B2 (fr)
AU428129B2 (fr)
AU442357B2 (fr)
AU442554B2 (fr)
AU410358B2 (fr)
AU417208B2 (fr)
AU442380B2 (fr)
AU442463B2 (fr)
AU425297B2 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse